Oncology Information Systems Market by Product & Service, Application, End User

ReportLinker

Oncology information systems manage data for various treatment schedules, treatment plans, and treatment delivery for each patient. The focus on establishing a standardization framework in OIS further advances the level of care for every cancer patient through a multidisciplinary approach.

New York, June 15, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Oncology Information System Market by Product and Service, Application, End User – Global Forecast to 2027” – https://www.reportlinker.com/p04880612/?utm_source=GNW

Factors such as increasing adoption of OIS solutions to reduce rising cost of care and rising incidence of cancer are expected to witness strong growth during the forecast period. For example, according to the National Cancer Institute, by 2040, new cases of cancer will increase by 29.5 million and the number of cancer-related deaths to 16.4 million per year. Additionally, the development of a wide range of new technologies will provide significant opportunities for the oncology information systems market during the forecast period.

The software segment held the largest share during the forecast period.
The software segment accounted for 83.6% of the oncology information system market for products and services in 2021. Software is a non-tangible component used to operate a system or perform major tasks, which include maintaining records. patient records and treatment planning in any healthcare organization or hospital. It is an integral part of the HCIT market and functions as an interface between the database and the end users. Healthcare organizations are shifting from on-premise models to web-based and cloud-based models, which is fueling the growth of this segment over the forecast period.

The radiation oncology segment held the largest share during the forecast period.
In 2021, the radiation oncology segment accounted for 53.8% of the application-based oncology information systems market. Radiation oncology specializes in treating cancer with radiation, delivering a high dose of radiation directly to the tumor to kill cancer cells with minimal exposure to healthy tissue surrounding the tumor. This limits complications, side effects, and side effects on healthy tissue, leading to advances in radiation oncology. Some of the new widely used radiation oncology therapies include external radiation therapy (EBRT), internal radiation therapy (IBRT), intraoperative radiation therapy (IORT), and brachytherapy. Integrating the radiation therapy system with OIS allows clinicians to accelerate the speed of radiation dose calculation and improve the overall efficiency of treatment planning.

The hospital and diagnostic imaging center segment held the largest share during the forecast period.
In 2021, hospitals and diagnostic imaging centers accounted for 64.5% of the oncology information systems market. Hospitals are the largest end-users of oncology information systems due to the large number of patient submissions/visits each year worldwide, increased government initiatives to equip (or modernize) hospitals with newer and advanced systems, the growing number of cancer care procedures, and the increasing adoption of oncology treatment care. Growing burden of various types of cancers and growing number of diagnostic procedures performed globally are some of the factors driving the growth of diagnostic imaging centers in the oncology information system market.

Asia-Pacific is expected to grow at the highest CAGR over the forecast period.
In 2021, Asia-Pacific accounted for 17.8% of the global oncology information systems market. The growth of the APAC market is driven by several factors, such as increasing investments for the advancement of healthcare IT infrastructure and increasing government support for the implementation of healthcare IT solutions in the health facilities. According to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan could reach 997,537 cases by 2040. The adoption of electronic medical records to utilize big data health information is a major priority in Japan. According to the Japanese government, in 2019, the adoption rate of electronic medical records and ordering systems in hospitals was 34.4% and 43.6% respectively.

In-depth interviews were conducted with CEOs, CMOs, other chief innovation and technology officers, and executives from various key organizations operating in the oncology information systems market.
• By type of business: Level 1: 46%, Level 2: 33% and Level 3: 21%
• By designation: C-level executives: 43%, directors: 35% and other: 22%
• By region: North America: 30%, Europe: 35%, APAC: 24%, Latin America: 14% and Middle East and Africa: 4%

Key players in the oncology information systems market are Koninklijke Philips NV (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US) , IBM (USA), Cerner Corporation (USA). ), Advanced Data Systems (USA), Bogardus Medical Systems, Inc (USA), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (USA), GE Healthcare (USA), Accuray Incorporated (USA), OPTUM (part of UnitedHealth Group) (USA), Allscripts Healthcare Solutions, Inc. (USA), MICA Information Systems, Inc. (USA), CureMD Healthcare (USA), EndoSoft LLC (USA), MIM Software Inc. (USA) and RaySearch Laboratories AB (Sweden).

Research Coverage:
This report describes and studies the products and services based on the global Oncology Information System Market, application, end-user, and regional level. It provides detailed information about the major factors influencing the growth of this market.

The report includes in-depth competitive analysis and product matrix of leading players in this market along with their company profiles, product portfolios, recent developments, and MNM overview.

Key Benefits of Purchasing the Report:
The report will assist market leaders/new entrants in this market and provide information on the closest approximations of revenue figures for the overall Oncology Information Systems market and its sub-segments. This report will help stakeholders understand the competitive landscape, better understand how to better position their businesses, and plan suitable go-to-market strategies.

The report will also help stakeholders understand the pulse of the market and provide insights into key market drivers, restraints, opportunities, and challenges.

This report provides information on:
• Market penetration: complete information on the product portfolios of the main players in the oncology information systems market. The report analyzes this market by product and services, application, end user and region.
• Market Development: Comprehensive information on lucrative emerging markets, by product and services, application, end user and region.
• Market Diversification: Comprehensive information on product portfolios, growing geographies, recent developments and investments in the oncology information systems market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of key players in the oncology information systems market.
Read the full report: https://www.reportlinker.com/p04880612/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Veronica J. Snell